SNEDDS curcumin formulation leads to enhanced protection from pain and functional deficits associated with diabetic neuropathy: An insight into its mechanism for neuroprotection

Anand, 2008, Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature, Biochem Pharmacol, 76, 1590, 10.1016/j.bcp.2008.08.008 Anand, 2007, Bioavailability of curcumin: problems and promises, Mol Pharmaceutics., 4, 807, 10.1021/mp700113r Wahlang, 2011, Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model, Eur J Pharm Biopharm, 77, 275, 10.1016/j.ejpb.2010.12.006 Munjal, 2011, Comparative oral bioavailability advantage from curcumin formulations, Drug Deliv Transl Res, 1, 322, 10.1007/s13346-011-0033-3 Pouton, 2008, Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies, Adv Drug Deliv Rev, 60, 625, 10.1016/j.addr.2007.10.010 Mohsin, 2009, Design of lipid-based formulations for oral administration of poorly water-soluble drugs: precipitation of drug after dispersion of formulations in aqueous solution, J Pharm Sci, 98, 3582, 10.1002/jps.21659 Dahan, 2008, Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs, J Control Release, 129, 1, 10.1016/j.jconrel.2008.03.021 Yallapu, 2012, Curcumin nanoformulations: a future nanomedicine for cancer, Drug Discov Today, 17, 71, 10.1016/j.drudis.2011.09.009 Hauss, 2007, Oral lipid-based formulations, Adv Drug Deliv Rev, 59, 667, 10.1016/j.addr.2007.05.006 Cameron, 2008, Pro-inflammatory mechanisms in diabetic neuropathy: focus on the nuclear factor kappa B pathway, Curr Drug Targets, 9, 60, 10.2174/138945008783431718 Sharma, 2006, Curcumin attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain, Eur J Pharmacol, 536, 256, 10.1016/j.ejphar.2006.03.006 Sharma, 2007, Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: participation of nitric oxide and TNF-alpha, Phytother Res, 21, 278, 10.1002/ptr.2070 Zhu, 2007, Formation of block copolymer-protected nanoparticles via reactive impingement mixing, Langmuir, 23, 10499, 10.1021/la701420z Negi, 2009, Functional and biochemical evidence indicating beneficial effect of melatonin and nicotinamide alone and in combination in experimental diabetic neuropathy, Neuropharmacology, 58, 585, 10.1016/j.neuropharm.2009.11.018 Negi, 2011, Nrf2 and NF-kappaB modulation by sulforaphane counteracts multiple manifestations of diabetic neuropathy in rats and high glucose-induced changes, Curr Neurovasc Res, 8, 294, 10.2174/156720211798120972 Ohkawa, 1979, Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction, Anal Biochem, 95, 351, 10.1016/0003-2697(79)90738-3 Negi, 2011, Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF-kappaB and Nrf2 cascades, J Pineal Res, 50, 124 Kumar, 2011, JSH-23 targets nuclear factor-kappa B and reverses various deficits in experimental diabetic neuropathy: effect on neuroinflammation and antioxidant defence, Diabetes Obes Metab, 13, 750, 10.1111/j.1463-1326.2011.01402.x Negi, 2010, Concurrent targeting of nitrosative stress-PARP pathway corrects functional, behavioral and biochemical deficits in experimental diabetic neuropathy, Biochem Biophys Res Commun, 391, 102, 10.1016/j.bbrc.2009.11.010 Calcutt, 2004, Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor, Diabetologia, 47, 718, 10.1007/s00125-004-1354-2 Cameron, 2001, Effect of alpha-lipoic acid on vascular responses and nociception in diabetic rats, Free Radic Biol Med, 31, 125, 10.1016/S0891-5849(01)00564-0 Anand, 2010, Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo, Biochem Pharmacol, 79, 330, 10.1016/j.bcp.2009.09.003 Yadav, 2010, Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake, Biochem Pharmacol, 80, 1021, 10.1016/j.bcp.2010.06.022 Sachs-Barrable, 2006, Influence of the lipid excipient, gelucire 44/14, on P-glycoprotein (P-gp) activity in an intestinal endothelial cell line (Caco-2), AAPS J, 8 Varma, 2005, Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo, Eur J Pharm Sci, 25, 445, 10.1016/j.ejps.2005.04.003 Zochodne, 1999, Diabetic neuropathies: features and mechanisms, Brain Pathol, 9, 369, 10.1111/j.1750-3639.1999.tb00233.x Feldman, 2003, Oxidative stress and diabetic neuropathy: a new understanding of an old problem, J Clin Invest, 111, 431, 10.1172/JCI17862 Negi, 2011, Oxidative stress and diabetic neuropathy: current status of antioxidants, IIOABJ, 2, 71 Negi, 2011, Oxidative stress and Nrf2 in the pathophysiology of diabetic neuropathy: old perspective with a new angle, Biochem Biophys Res Commun, 408, 1, 10.1016/j.bbrc.2011.03.087 Meghana, 2007, Curcumin prevents streptozotocin-induced islet damage by scavenging free radicals: a prophylactic and protective role, Eur J Pharmacol, 577, 183, 10.1016/j.ejphar.2007.09.002 Suryanarayana, 2007, Effect of turmeric and curcumin on oxidative stress and antioxidant enzymes in streptozotocin-induced diabetic rat, Med Sci Monit, 13, BR286 Brownlee, 2001, Biochemistry and molecular cell biology of diabetic complications, Nature, 414, 813, 10.1038/414813a Aggarwal, 2009, Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases, Int J Biochem Cell Biol, 41, 40, 10.1016/j.biocel.2008.06.010 Kellogg, 2007, Protective effects of cyclooxygenase-2 gene inactivation against peripheral nerve dysfunction and intraepidermal nerve fiber loss in experimental diabetes, Diabetes, 56, 2997, 10.2337/db07-0740 Zochodne, 2005, Nitric oxide in damage, disease and repair of the peripheral nervous system, Cell Mol Biol (Noisy-le-Grand), 51, 255 Levy, 2004, NO pain: potential roles of nitric oxide in neuropathic pain, Pain Pract, 4, 11, 10.1111/j.1533-2500.2004.04002.x Sommer, 2001, Anti-TNF-neutralizing antibodies reduce pain-related behavior in two different mouse models of painful mononeuropathy, Brain Res, 913, 86, 10.1016/S0006-8993(01)02743-3 Hayden, 2004, Signaling to NF-kappaB, Genes Dev, 18, 2195, 10.1101/gad.1228704